(Q47581475)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29134272%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

title

CXCL13 as a diagnostic marker of neuroborreliosis and other neuroinflammatory disorders in an unselected group of patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29134272%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29134272%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Tim von Oertzen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29134272%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

author name string

S Weis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29134272%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

C Kubasta

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29134272%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

J Panholzer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29134272%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

publication date

13 November 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29134272%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29134272%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

volume

265

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29134272%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29134272%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

page(s)

74-81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29134272%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00415-017-8669-7

2 April 2020

exact match

0 references

cites work

Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8669-7

CXCL13 antibody for the treatment of autoimmune disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8669-7

Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8669-7

CSF cytokines/chemokines as biomarkers in neuroinflammatory CNS disorders: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8669-7

CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8669-7

Targeting CXCL13 During Neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8669-7

Cognitive function in post-treatment Lyme disease: do additional antibiotics help?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8669-7

Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8669-7

Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8669-7

Laboratory diagnosis of Lyme neuroborreliosis: a comparison of three CSF anti-Borrelia antibody assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8669-7

CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8669-7

Acute HIV-1 infection presenting with fulminant encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8669-7

Encephalitis in primary HIV infection: challenges in diagnosis and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8669-7

Primary HIV infection presenting as limbic encephalitis and rhabdomyolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8669-7

Dysregulation of germinal centres in autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8669-7

Serum levels of CXCL13 are elevated in active multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8669-7

Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8669-7

CXCL13 and CXCL12 in central nervous system lymphoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8669-7

CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8669-7

CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8669-7

Expression and clinical significance of CXCR5/CXCL13 in human non‑small cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8669-7

CXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-017-8669-7

A prospective study on the role of CXCL13 in Lyme neuroborreliosis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29134272

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The chemokine CXCL13 in acute neuroborreliosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29134272

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1 reference

https://pubmed.ncbi.nlm.nih.gov/29134272

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00415-017-8669-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29134272%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference